logo
Plus   Neg
Share
Email

BGC Partners Appoints Steven Bisgay As CFO To Replace Sean Windeatt

BGC Partners, Inc. (BGCP) announced Friday changes to its leadership team, primarily the appointment of Steven Bisgay as Chief Financial Officer, effective January 1, 2020. Bisgay will replace Sean Windeatt, who was Interim CFO.

Windeatt will remain in his role as Chief Operating Officer of BGC. As CFO of BGC, Bisgay will to report to Howard Lutnick, Chairman of the Board and Chief Executive Officer of BGC.

Bisgay is a seasoned industry veteran with 30 years of experience in the securities and financial services industry who has significant experience with financial technology companies. Since 2015, he has served as CFO of Cantor Fitzgerald, L.P., overseeing financial operations.

Prior to his time at Cantor, Bisgay was CFO at KCG Holdings, Inc. and prior to that, he served as CFO and COO, Head of Business Development, Group Controller, and Director of Internal Audit at Knight Capital Group, Inc. He also previously served as Senior Manager at PricewaterhouseCoopers, LLP.

The company has also appointed Anthony Warner and Julian Swain the newly created positions of Co-Heads of Global Brokerage alongside Jean-Pierre Aubin, Global Head of Listed Products and Paris. All three will report to Shaun Lynn, President of BGC.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
RELATED NEWS
Follow RTT